Morphotek(R), Inc. Announces Initiation Farletuzumab Phase II Study In Platinum-Resistant Ovarian Cancer (also known as MORAb-003) Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Tuesday, December 02, 2008

Morphotek(R), Inc. Announces Initiation Farletuzumab Phase II Study In Platinum-Resistant Ovarian Cancer (also known as MORAb-003)



0 comments :

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.